Frontiers in Pharmacology | Renal Pharmacology

Brief Research Report

Published on 05 Feb 2024

Mitophagy regulates mitochondrial number following pharmacological induction of mitochondrial biogenesis in renal proximal tubule cells

in Renal Pharmacology

Kevin A. Hurtado
Rick G. Schnellmann

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1344075

1,998 views
3 citations

Brief Research Report

Published on 01 Feb 2024

Determination of glomerular filtration rate “en passant” after high doses of iohexol for computed tomography in intensive care medicine—a proof of concept

in Renal Pharmacology

Alexander Dejaco
Christoph Dorn
Michael Paal
Michael Gruber
Bernhard M. Graf
Martin G. Kees

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1346343

1,856 views

Original Research

Published on 23 Jan 2024

Unravelling the role of Sildenafil and SB204741 in suppressing fibrotic potential of peritoneal fibroblasts obtained from PD patients

in Renal Pharmacology

Saurabh Chaturvedi
Harshit Singh
Vikas Agarwal
Akhilesh Jaiswal
Narayan Prasad

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1279330

1,746 views
1 citation

Mini Review

Published on 22 Jan 2024

Ceftazidime-avibactam induced renal disorders: past and present

in Renal Pharmacology

Yanrong Shi
Jichao Wu
Wei Mi
Xusheng Zhang
Xiuli Ren
Chengwu Shen
Cuicui Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1329307

3,045 views
3 citations

Review

Published on 19 Jan 2024

Urinary biomarkers associated with podocyte injury in lupus nephritis

in Renal Pharmacology

Zhiying Guo
Qianyu Guo
Xiaochen Li
Xinnan Gao
Liyun Zhang
Ke Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1324540

3,140 views
3 citations

Original Research

Published on 19 Jan 2024

Kidney derived apolipoprotein M and its role in acute kidney injury

in Renal Pharmacology

Line S. Bisgaard
Pernille M. Christensen
Jeongah Oh
Federico Torta
Ernst-Martin Füchtbauer
Lars Bo Nielsen
Christina Christoffersen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1328259

2,075 views

Review

Published on 16 Jan 2024

The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis

in Renal Pharmacology

Na Ren
Wen-Feng Wang
Liang Zou
Yan-Long Zhao
Hua Miao
Ying-Yong Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1335094

5,118 views
8 citations

Editorial

Published on 15 Jan 2024

Editorial: Transporters: a hitchhiker’s guide to physiology, toxicology, and pharmacology—TransportDays 2022

in Renal Pharmacology

Giuliano Ciarimboli
Rosalinde Masereeuw
Stefan Oswald

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1365106

969 views

Systematic Review

Published on 11 Jan 2024

Tumor risks of finerenone in patients with type 2 diabetes mellitus complicated with chronic kidney disease: a meta-analysis and systematic review of randomized controlled trials

in Renal Pharmacology

Yue Du
Gui Cao
Linlin Gu
Yuehong Chen
Jingyu Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1237583

2,252 views
2 citations

Original Research

Published on 09 Jan 2024

Using real-world data to inform dosing strategies of rituximab for pediatric patients with frequent-relapsing or steroid-dependent nephrotic syndrome: a prospective pharmacokinetic-pharmacodynamic study

in Renal Pharmacology

Yewei Chen
Qian Shen
Ye Xiong
Min Dong
Hong Xu
Zhiping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1319744

1,856 views

Editorial

Published on 09 Jan 2024

Editorial: Global excellence in renal pharmacology 2022: Central and South America

in Renal Pharmacology

Vinicius Andrade-Oliveira
Orestes Foresto-Neto
Niels Olsen Saraiva Câmara

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1362010

836 views

Review

Published on 08 Jan 2024

Pharmacological functions of salidroside in renal diseases: facts and perspectives

in Renal Pharmacology

Qiong Liu
Jianzhu Chen
Anqi Zeng
Linjiang Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1309598

15,759 views
12 citations

Original Research

Published on 08 Jan 2024

Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China

in Renal Pharmacology

Li Zeng
Huihui Chen
Heng Xiang
Mengru Zeng
Mi Zhou
Chongqing Tan
Hong Liu
Guochun Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1309930

1,919 views

Original Research

Published on 03 Jan 2024

Klotho-derived peptide KP1 ameliorates SARS-CoV-2-associated acute kidney injury

in Renal Pharmacology

Jie Xu
Enqing Lin
Xue Hong
Li Li
Jun Gu
Jinghong Zhao
Youhua Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1333389

2,807 views
6 citations

Original Research

Published on 22 Dec 2023

Efficacy and safety of rituximab in elderly patients with membranous nephropathy

in Renal Pharmacology

Yanhong Guo
Huayan Zhao
Mingjing Ren
Yulin Wang
Liuwei Wang
Lin Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1323334

2,246 views
1 citation

Systematic Review

Published on 15 Dec 2023

Anticoagulant drugs for patients with atrial fibrillation on dialysis: a systematic analysis and network meta-analysis

in Renal Pharmacology

Xian-Feng Shen
Chao Zhang
Jun Hu
Tao Zhang
Bin Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1320939

3,992 views
2 citations

Navigation group

Articles

Mitophagy regulates mitochondrial number following pharmacological induction of mitochondrial biogenesis in renal proximal tubule cells

Determination of glomerular filtration rate “en passant” after high doses of iohexol for computed tomography in intensive care medicine—a proof of concept

Unravelling the role of Sildenafil and SB204741 in suppressing fibrotic potential of peritoneal fibroblasts obtained from PD patients

Ceftazidime-avibactam induced renal disorders: past and present

Urinary biomarkers associated with podocyte injury in lupus nephritis

Kidney derived apolipoprotein M and its role in acute kidney injury

The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis

Editorial: Transporters: a hitchhiker’s guide to physiology, toxicology, and pharmacology—TransportDays 2022

Tumor risks of finerenone in patients with type 2 diabetes mellitus complicated with chronic kidney disease: a meta-analysis and systematic review of randomized controlled trials

Using real-world data to inform dosing strategies of rituximab for pediatric patients with frequent-relapsing or steroid-dependent nephrotic syndrome: a prospective pharmacokinetic-pharmacodynamic study

Editorial: Global excellence in renal pharmacology 2022: Central and South America

Pharmacological functions of salidroside in renal diseases: facts and perspectives

Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China

Klotho-derived peptide KP1 ameliorates SARS-CoV-2-associated acute kidney injury

Efficacy and safety of rituximab in elderly patients with membranous nephropathy

Anticoagulant drugs for patients with atrial fibrillation on dialysis: a systematic analysis and network meta-analysis